Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Algernon Pharmaceuticals Inc. AGNPF


Primary Symbol: C.AGN

Algernon Pharmaceuticals is a clinical stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough. The company's business model is highly capital efficient and strives to deliver maximum shareholder value. Algernon's unique approach to drug discovery is based on the concept of drug repurposing.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (OTCQB:AGNPF)

Fundamentals Snapshot (OTCQB:AGNPF)

Bullboard Posts (CSE:AGN)

RE:RE:AGN.c upcoming milestones

Without an uplist to NASDAQ this stock will most likely remain in the gutter. People want to see data and uplist ro NASDAQ. They have...
C10H12N2 - 1 hour ago

RE:AGN.c upcoming milestones

With one study in progress and another incoming, AGN is has an established plan for this year and could easily see some catalysts here....
waves1 - 20 hours ago

Experts Fear Bird Flu Outbreak Could Turn Into New Pandemic

The spread of the avian influenza virus on a mink farm in Spain has some scientists on edge. “This is an infection that has epidemic...
C10H12N2 - 1 day ago

AGN.c upcoming milestones

Lot of upcoming milestones which could get AGN moving. Look out for data from phase 1 of the DMT study in Q2 of this year along with the...
StockDoctor101 - 3 days ago

CEO Interview on Ifenprodil for Chronic Cough

New interview with AGN.c AGNPF CEO (up 5% today). Gives updates on the previously announced 180 patient, 90-day Phase 2b clinical...
SkywalkerofLuke - 4 days ago

RE:The CEO Wants You To Believe It's Current Market Conditions.

oops!
C10H12N2 - 5 days ago